Boston Financial Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $277K | Buy |
8,182
+58
| +0.7% | +$1.96K | 0.01% | 294 |
|
|
2024
Q3 | $332K | Hold |
8,124
| – | – | 0.01% | 277 |
|
|
2024
Q2 | $313K | Hold |
8,124
| – | – | 0.01% | 281 |
|
|
2024
Q1 | $348K | Hold |
8,124
| – | – | 0.01% | 280 |
|
|
2023
Q4 | $301K | Hold |
8,124
| – | – | 0.01% | 281 |
|
|
2023
Q3 | $294K | Sell |
8,124
-2,500
| -24% | -$90.6K | 0.01% | 269 |
|
|
2023
Q2 | $379K | Buy |
+10,624
| New | +$379K | 0.01% | 254 |
|
|
2018
Q3 | – | Sell |
-6,400
| Closed | -$322K | – | 298 |
|
|
2018
Q2 | $322K | Sell |
6,400
-2,844
| -31% | -$143K | 0.02% | 220 |
|
|
2018
Q1 | $451K | Hold |
9,244
| – | – | 0.03% | 194 |
|
|
2017
Q4 | $410K | Hold |
9,244
| – | – | 0.03% | 207 |
|
|
2017
Q3 | $469K | Hold |
9,244
| – | – | 0.03% | 198 |
|
|
2017
Q2 | $498K | Hold |
9,244
| – | – | 0.04% | 202 |
|
|
2017
Q1 | $487K | Hold |
9,244
| – | – | 0.04% | 208 |
|
|
2016
Q4 | $445K | Hold |
9,244
| – | – | 0.04% | 209 |
|
|
2016
Q3 | $498K | Hold |
9,244
| – | – | 0.04% | 200 |
|
|
2016
Q2 | $501K | Buy |
+9,244
| New | +$501K | 0.04% | 193 |
|